Our Latest News - BUHLMANN

BUHLMANN News

LabSense News Q3 2025 Edition

In this LabSense News Q3 2025 we're covering New Partnership-Worldwide Collaboration with QuidelOrtho, Technical News- CALEX® Updates & New Automation Video, Product Highlights- ACE kinetic Enzymatic Assay, Recent Events - ADLM, AMLI.
Continue Reading

Connect with BUHLMANN at AMLI 2025

At BUHLMANN Diagnostics Corp, we empower healthcare professionals with innovative diagnostic tools —led by our trusted Calprotectin portfolio—for confident clinical decisions. Explore the science behind our accuracy and discover our RUO Allergy and Neuroimmunology solutions.

Continue Reading

QuidelOrtho and BÜHLMANN Laboratories AG Announce Availability of Fecal Calprotectin (fCAL) turbo and Fecal Pancreatic Elastase(fPELA) turbo Assays on Vitros™ Systems as a Microtip™ Partnership Assay (MPA)

Gastrointestinal biomarker tests enhance patient diagnosis of IBD and pancreatic insufficiency on leading clinical chemistry platforms San Diego, CA, July 2025- QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL® turbo and fPELA® turbo assays on QuidelOrtho's VITROS Systems as an MPA. Both particle-enhanced turbidimetric immunoassays, the
Continue Reading

BUHLMANN Diagnostics Corp – New Collaboration with QuidelOrtho

BUHLMANN Diagnostic Corp – New Partner Channel Agreement with Roche Diagnostics.

Continue Reading

Visit BUHLMANN at ADLM 2025

At BUHLMANN Diagnostics Corp, we empower healthcare professionals with innovative diagnostic tools —led by our trusted Calprotectin portfolio—for confident clinical decisions. Explore the science behind our accuracy and discover our RUO Allergy and Neuroimmunology solutions.

Continue Reading

Product Highlights – ACE Kinetic Enzymatic Assay

BÜHLMANN ACE Kinetic Enzymatic Assay Unique in Speed, Quality, Flexibility Automated Assay for use on Multiple Clinical Chemistry Platforms ACE kinetic is FDA 510(k) Exempt. For in vitro Diagnostic Use. Overview BÜHLMANN’s Clinical Chemistry product line offers a unique selection of high-quality assays for both routine and specialized clinical chemistry testing. With extensive expertise in ACE activity measurement
Continue Reading

CALEX® Cap

BÜHLMANN fCAL® turbo + CALEX® Cap (K191718 & K232057): FDA 510(k) cleared. For in vitro Diagnostic Use. CALEX® Cap Stool Preparation Device- for fecal Calprotectin & fecal Pancreatic Elastase The BÜHLMANN CALEX® Cap is designed to provide convenient and safe stool extraction of multiple analytes. The optimized dilution of stool sample yields maximum extraction efficiency and analyte
Continue Reading

Visit BUHLMANN at DDW 2025

Product Highlights DDW 2025 Venue Buhlmann Team Product Highlights We offer a comprehensive gastroenterology testing portfolio, featuring a range of assays for fecal calprotectin (fCAL), pancreatic elastase, and therapeutic drug monitoring (TDM). Our fCAL testing lineup includes the FDA 510(k)-cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo, and CALEX® Cap, as well as the Research Use
Continue Reading

BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BÜHLMANN fCAL turbo and fPELA turbo Assays

Amherst NH, September 2024- BÜHLMANN Laboratories AG, a leading manufacturer of specialty, high-quality in-vitro diagnostic and research assays, is pleased to announce the collaboration with Beckman Coulter for a worldwide distribution of the BÜHLMANN fCAL® turbo assay & BÜHLMANN fPELA® turbo assay on their clinical chemistry analyzers (AU480, AU680, AU5800, and DxC 700 AU) with
Continue Reading

AMLI 2024 Recap for BUHLMANN Diagnostics Corp

Key Highlights BUHLMANN Diagnostics Corp proudly participated in the 37th Annual Meeting of the Association of Medical Laboratory Immunologists (AMLI) from August 16-19, 2024, in Nashville, Tennessee. This event was a significant platform for showcasing our latest advancements and contributions to medical laboratory immunology. AMLI 2024 Assay Offerings Our booth showcased a comprehensive immunology assay
Continue Reading